FDA commissioner nominee Dr. Heidi Overton appears for confirmation hearing
Also reported by PBS NewsHour
Summary
Dr. Heidi Overton is having a Senate hearing to become the next leader of the Food and Drug Administration (FDA). President Donald Trump nominated her, and if approved, she will take over after the earlier FDA chief, Marty Makary, left the job.Key Facts
- Dr. Heidi Overton appeared before the Senate Health, Education, Labor, and Pensions committee for her FDA commissioner confirmation.
- She was nominated by President Donald Trump in August 2026.
- Overton has worked as Trump’s deputy assistant for domestic policy during his second term.
- The previous FDA commissioner, Marty Makary, resigned amid conflicts with lawmakers, drug companies, and the president.
- Kyle Diamantas has been acting FDA commissioner since May 2026.
- Overton has been involved in health policy work, including efforts to lower drug prices and changes to childhood vaccine guidelines.
- She holds medical and doctoral degrees from the University of New Mexico and Johns Hopkins University.
- Overton worked at the America First Policy Institute before joining the White House, a group linked to Trump administration officials.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
